Apotheker Silke Christiaens SRL
Apotheker Silke Christiaens reported total assets of 37,111 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Mar 2026).
The score of Apotheker Silke Christiaens shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheker Silke Christiaens's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 09 Mar 2026
- Year ended 30 Sep 2024filed on 11 Apr 2025
- Year ended 30 Sep 2023filed on 11 Mar 2024
- Year ended 30 Sep 2022filed on 27 Mar 2023
- Year ended 30 Sep 2021filed on 04 Apr 2022
Apotheker Silke Christiaens's financial analysis
- Solvency-0.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheker Silke Christiaens
Apotheker Silke Christiaens's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0635.571.516
- VAT number
- BE0635571516
- Peppol
- Registered · 0208:0635571516 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Aug 2015
- Registered office
- 1750 Lennik
- Latest accounts
- 2025 · filed on 09 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheker Silke Christiaens (SRL) has been based in Lennik since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,437 € and equity of −15 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheker Silke Christiaens
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- PharmAzzy Retail sale of pharmaceutical products Zonhoven · balance sheet 37,787 €
- Taxapharm Retail sale of pharmaceutical products Waterloo · balance sheet 35,480 €
- Pharmavanty Retail sale of pharmaceutical products Ninove · balance sheet 34,846 €
- WE Farma Retail sale of pharmaceutical products Oosterzele · balance sheet 39,748 €
- P.Stievanin Partner Solutions Retail sale of pharmaceutical products Binche · balance sheet 39,868 €
- VanbaelenApo Retail sale of pharmaceutical products Bruges · balance sheet 39,958 €
- NL Pharma Retail sale of pharmaceutical products Florennes · balance sheet 33,758 €
Frequently asked questions about Apotheker Silke Christiaens
What is the revenue of Apotheker Silke Christiaens?
Apotheker Silke Christiaens files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheker Silke Christiaens?
In Belgium, the VAT number is the company number prefixed with BE: BE0635571516 for Apotheker Silke Christiaens, if the company is VAT-registered. Its company number (CBE) is 0635.571.516.
Where is the registered office of Apotheker Silke Christiaens?
According to the CBE register, the registered office of Apotheker Silke Christiaens is in 1750 Lennik.
What is the equity of Apotheker Silke Christiaens?
At the close of the 2025 financial year, the equity of Apotheker Silke Christiaens amounts to -15 €, a solvency of -0.0% of total assets.
Who manages Apotheker Silke Christiaens?
The register lists 1 active mandates at Apotheker Silke Christiaens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheker Silke Christiaens
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →